Article info

Download PDFPDF

Discussion of off-target and tentative genomic findings may sometimes be necessary to allow evaluation of their clinical significance

Authors

  • Rachel H Horton Clinical Ethics, Law and Society, Wellcome Trust Centre for Human Genetics, Oxford, UK Centre for Personalised Medicine, St Anne's College, Oxford, UK Clinical Ethics, Law and Society, University of Southampton, Southampton, UK PubMed articlesGoogle scholar articles
  • William L Macken Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK NHS Highly Specialised Service for Rare Mitochondrial Disorders, Queen Square Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, London, UK PubMed articlesGoogle scholar articles
  • Robert D S Pitceathly Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, UK NHS Highly Specialised Service for Rare Mitochondrial Disorders, Queen Square Centre for Neuromuscular Diseases, The National Hospital for Neurology and Neurosurgery, London, UK PubMed articlesGoogle scholar articles
  • Anneke M Lucassen Clinical Ethics, Law and Society, Wellcome Trust Centre for Human Genetics, Oxford, UK Centre for Personalised Medicine, St Anne's College, Oxford, UK Clinical Ethics, Law and Society, University of Southampton, Southampton, UK PubMed articlesGoogle scholar articles
  1. Correspondence to Professor Anneke M Lucassen, CELS, Wellcome Trust Centre for Human Genetics, Oxford OX3 7BN, UK; anneke.lucassen{at}well.ox.ac.uk
View Full Text

Citation

Horton RH, Macken WL, Pitceathly RDS, et al
Discussion of off-target and tentative genomic findings may sometimes be necessary to allow evaluation of their clinical significance

Publication history

  • Received March 21, 2023
  • Accepted June 8, 2023
  • First published June 20, 2023.
Online issue publication 
May 09, 2024

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.